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To evaluate binding potential of Prunus domestica gum in tablets formulations. Six tablet batches (F-
1B to F-6B) were prepared by wet granulation method, containing Avicel pH 101 as diluent, sodium 
diclofenac as model drug using 10, 15 and 20 mg of Prunus domestica gum as binder and PVP K30 was 
used as standard binder. Magnesium stearate was used as lubricant. Flow properties of granules like bulk 
density, tapped density, Carr index, Hausner’s ratio, angle of repose as well as physical parameters of 
the compressed tablets including hardness, friability, thickness and disintegration time were determined 
and found to be satisfactory. The FTIR spectroscopic analysis showed that the formulation containing 
plant gum is compatible with the drug and other excipients used in tablets formulation. Hence the plant 
gum has role as a potential binder in tablets formulations. The dissolution profile showed that tablets 
formulations containing Prunus domestica gum 15 mg/200 mg of total weight of tablet as binder showed 
better results as compared to PVP K30.
Uniterms: Prunus domestica/pharmaceutics. Plant gum/binder property. Plant binder. Tablets/
formulations. Sodium diclofenac/tablets/analysis.
Para avaliar a propriedade aglutinante da goma Prunus domestica em formulações de comprimidos, seis 
lotes (F-1B para F-6B) foram preparados pelo método de granulação úmida, contendo Avicel pH 101 
como diluente e diclofenaco de sódio como fármaco modelo, usando 10, 15 e 20 mg de goma de Prunus 
domestica como agente aglutinante e PVP K30 como aglutinante padrão. O estearato de magnésio foi 
utilizado como lubrificante. Propriedades de fluxo dos grânulos, como a densidade, índice de Carr, razão 
de Hausner, ângulo de repouso, bem como parâmetros físicos dos comprimidos, incluindo o tempo de 
dureza, friabilidade, espessura e desintegração foram determinados e se mostraram satisfatórios. A análise 
espectroscópica no FTIR mostrou que a formulação contendo goma vegetal é compatível com o fármaco e 
outros excipientes utilizados na formulação dos comprimidos. Assim, a goma vegetal tem papel potencial 
como aglutinante em formulações de comprimidos. O perfil de dissolução das formulações que contêm 
15 mg/200 mg do peso total do comprimido em goma de Prunus domestica como aglutinante mostrou 
melhores resultados comparativamente ao PVP K30.
Unitermos: Prunus domestica/farmacotécnica. Goma vegetal/propriedade aglutinante. Aglutinante 
vegetal. Comprimidos/formulações. Diclofenaco de sódio/comprimidos/análise.
INTRODUCTION
Gum is a by-product obtained as an outcome 
of metabolic mechanism of plants. Gums obtained 
from natural sources either absorb water to form a 
viscous solution or water soluble. These gums are easily 
available, less expensive and also employed as excipient 
in pharmaceutical formulations (Sarojini et al., 2010). 
Plant derived natural polysaccharides are more suitable 
pharmaceutical excipient due to non-toxicity, stability, 
availability, renewability and are, therefore, extensively 
used as matrix formers in modified release dosage 
forms (Beneke, Viljoen, Hamman, 2009; Nep, Conway, 
2010). Natural gums obtained from plants have various 
applications in drug delivery as disintegrant, emulsifying 
agent, suspending agents, binders and are also useful in 
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formulating immediate and sustained release preparations 
(Ibrahim, Dawes, Bangudu, 2000; Sinha, Kumaria, 2002; 
Oluwatoyin, 2005; Emeje et al., 2009).
Prunus domestica belongs to family Rosaceae, are 
small to medium size trees, found throughout Pakistan 
including Azad Jammu and Kashmir region (Gilani et 
al., 2011). Prunus domestica fruits are used locally to 
treat jaundice and hepatitis and its gum is used as a tonic, 
laxative, and vermifuge (Abbasi et al., 2009; Lardos, 
Prietos-Garcia, Heinrich, 2011). Diclofenac sodium 
is a non-steroidal anti-inflammatory drug (NSAID), 
which is poorly soluble in water and freely soluble in 
organic solvent like methanol. It is commonly used as 
analgesic, antipyretic, anti-inflammatory and for the 
long-term treatment of rheumatoid arthritis (Ganish et 
al., 2010). Plant gums have been used as binders in tablet 
formulations. They are useful for imparting the structural 
strength required during the processing, handling and 
packaging of tablets as well as these plant gums are of 
non-toxic nature and widely available.
No work has been done on Prunus domestica gum 
as tablet binder. Hence the gum is widely available and 
need to be evaluated by using as an excipient in tablet 
formulations.
MATERIAL AND METHODS
Material
Diclofenac sodium, Avicel pH 101, Aerosil, 
magnesium stearate and PVP K30 were provided by 
Prays Pharmaceuticals (Pvt) Ltd, Islamabad, Pakistan. 
Hydrochloric acid, methanol, sodium hydroxide and 
potassium dihydrogen phosphate were purchased from 
Musaji and Sons, Khyber Bazaar, Peshawar, Pakistan. All 
other chemicals used were of analytical grade.
Collection of Prunus domestica gums
Gums were collected from the plants of P. domestica, 
(Family Rosaceae) in April, 2010 from Sheringal valley 
of District Dir Upper, Khyber Pakhtunkhwa, Pakistan. 
Gums were natural exudates on the bark of the plant. 
The plant was identified by Prof. Dr. Jehandar Shah, Vice 
Chancellor, Shaheed Benazir Bhutto University, Sheringal 
(Dir Upper) Khyber Pakhtunkhwa, Pakistan. The specimen 
sample (PG-02-10) was kept in Department of Pharmacy, 
University of Malakand, Chakdara, Dir Lower, Khyber 
Pakhtunkhwa, Pakistan. After collection, gums were dried 
in oven at 60 °C. Gums were then hydrated to remove 
extraneous materials by straining through a muslin cloth. 
The gums were then precipitated from the solution using 
absolute acetone. The precipitate was separated, dried in 
oven at 50 °C and stored in tightly closed container for 
future use as binder in formulating matrix tablets.
Preparation and evaluation of granules
Granules of various formulations containing 50 mg 
of sodium diclofenac were prepared by wet granulation 
method. Natural gum (Prunus domestica) in different 
ratios was used as binder and PVP K30 as a standard 
binder. Diclofenac sodium, Avicel pH 101, Aerosil and 
gum were separately mixed, thoroughly, and sufficient 
quantity of water was added as granulating agent. The 
damp mass was passed through mesh 12. Granules 
obtained were allowed to dry at 60 °C for 4-5 hours and 
were then passed through mesh 18. Finally magnesium 
stearate was added as lubricant to each batch prior to 
compression of granules. The quantities of ingredients of 
all the formulation batches are given in Table I.
Evaluation of granules
The bulk density, tapped density, Hausner’s ratio, 
compressibility index and angle of repose were determined 
for each batch of dried granules.
Bulk density
Granules of known weight (m) were poured in 
10 mL graduated cylinder, unsettled volume (V0) was 
noted and bulk density was calculated (g/mL) by formula 
m/V0 (Lachman, Lieberman, Kanig 2003).
Tapped density
The graduated cylinder (10 mL) containing known 
weight (m) of granules was tapped on a hard surface until 
no further change in volume was observed. The tapped 
volume (VT) was noted and tapped density was calculated 
by putting values in formula, m/ VT (Bamiro et al., 2010).
Compressibility index
It was determined by Carr’s compressibility index 
i.e. by formula given:
Compressibility index= (Td-Bd / Td) × 100
where Td is tapped density and Bd is bulk density.
Hausner’s ratio
It was calculated by the following formula 
(Shivanand, 2010):
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TABLE I – Formulation of different batches of sodium diclofenac tablets
Ingredients (mg) F-1B F-2B F-3B F-4B F-5B  F-6B
Diclofenac sodium 50 50 50 50 50 50 
Prunus domestica gum 10 15 20 --- --- ---
Avicel pH 101 133 128 123 133 128 123 
PVP K30 (binder) --- --- --- 10 15 20
Aerosil 4 4 4 4 4 4
Distilled water q.s q.s q.s q.s q.s q.s
Magnesium stearate 3 3 3 3 3 3
Total weight (mg) 200 200 200 200 200 200
Key: --- means absent
Hausner’s ratio= Td/Bd
where Td is tapped and Bd is bulk density.
Angle of repose
It was determined by filling 10 g of powder in a 
funnel. Then, the funnel was opened to release the powder 
on the paper to form a conical heap. The values were 
calculated by formula (Shivanand., 2010),
tan θ = h/r or θ = tan-1 h/r
where h = height of the heap; r = radius of the heap 
Preparation of sodium diclofenac tablets
Tablets were prepared by compressing granules on 
rotary compression machine using concave punch (8 mm). 
Total weight of tablet was kept as 200 mg (ZP19 Rotary 
Tablet Press, Shanghai, China).
Evaluation of tablets
Average weight
Twenty tablets were weighed by analytical balance 
(Sartorius BL 2105, Germany) after compression, then 
average weight and standard deviation was determined 
(United States Pharmacopoeia, 2004).
Drug Content
Tablets (10) were accurately weighed and powdered. 
Powder amount equivalent to 50 mg Diclofenac sodium 
was shaken with 60 mL of methanol in a 200 mL 
volumetric flask and final volume was make up with 
methanol, 5 mL of this solution was further diluted to 
100 mL with methanol and absorbance was measured 
using spectrophotometer (UV-1601 Shimadzu, Japan) at 
276 nm. The content was determined by preparing same 
concentration of sodium diclofenac in the same solvent 
and absorbance was measured at 276 nm. The % content 
was determined by (Shingala et al., 2010): 
Hardness
Hardness of 10 tablets was determined by using 
digital hardness tester (Pharma Test) and mean ± S.D. of 
each formulation mentioned in Table III (Shingala et al., 
2010).
Thickness
The thickness of 10 tablets was determined using 
vernier calipers and average values were calculated 
(Shingala et al., 2010).
Friability
The friability of tablets (10) was determined using 
Roche Friabilator. Ten tablets were initially weighed 
(W0) and transferred into friabilator. The friabilator was 
operated at 25 rpm for 4 minutes or was run up to 100 
revolutions. The tablets were weighed again (W). The % 
friability was then calculated (Shivanand., 2010):
% Friability= (W0-W)/W0 ×100
where W0=initial weight of 10 tablets; W= weight of 10 
tablets after 100 revolutions; % Friability of tablets less 
than 1% were considered acceptable.
Disintegration time
The method specified in the USP/NF (2007) was 
followed for Disintegration time, medium used was 100 mL 
of 0.1 N HCl maintained at temperature between 37±2 ºC 
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throughout the experiment. Five tablets were randomLy 
selected from each batch and were placed one in each of 
the cylindrical tubes of the basket using disintegration test 
apparatus (DT-0607, Curio) but no disc was used. The time 
taken for each tablet to break up into small particles and pass 
out through the mesh was noted (Satyam., 2010).
In-Vitro dissolution studies
In-vitro dissolution test of the all the batches 
compressed Diclofenac sodium tablet was performed 
using USP dissolution apparatus 2 (Pharma Test DT-70, 
Germany), using phosphate buffer pH 6.8 as dissolution 
medium. The temperature was maintained at 37±2 ºC 
using rotation speed 50 rpm. Samples were withdrawn at 
regular intervals (10 minutes) up to 1hour, replacing equal 
amount of fresh dissolution medium (phosphate buffer pH 
6.8). Samples were analyzed using UV spectrophotometer 
at 276 nm and % cumulative drug release was calculated 
(Satyam., 2010).
Release kinetics
Different kinetic models (zero-order, first-order, 
Higuchi’s, and Korsmeyer’s equation) were applied to 
interpret the release profile (the order and mechanism 
of sodium diclofenac release) from tablet. To study the 
mechanism of drug release from the tablets, the release 
data were fitted to zero-order, first-order, and Higuchi 
equation. However, two factors diminish the applicability 
of Higuchi’s equation to matrix systems. This model fails 
to allow the influence of swelling of the matrix (upon 
hydration) and gradual erosion of the matrix. Therefore, 
the dissolution data were also fitted according to the 
well-known exponential equation (Korsmeyer equation), 
Eq. (1), which is often used to describe the drug release 
behavior from polymeric systems. 
 Log (Mt /Mf) = Log k + n Log t  (1)
where, Mt is the amount of drug release at time t; Mf is 
the amount of drug release after infinite time; k is a release 
rate constant incorporating structural and geometric 
characteristics of the tablet; and n is the diffusional 
exponent indicative of the mechanism of drug release. 
To clarify the release exponent for different batches of 
matrix tablets, the log value of percentage drug dissolved 
was plotted against log time for each batch according to 
the equation 1. A value of n = 0.45 indicates Fickian (case 
I) release; >0.45 but <0.89 for non-Fickian (anomalous) 
release; and >0.89 indicates super case II type of release. 
Case II generally refers to the erosion of the polymeric 
chain and anomalous transport (non-Fickian) refers to a 
combination of both diffusion and erosion controlled-drug 
release (Siva PG, Mohini K, 2012).
FTIR Studies
To study any possible interaction between drug and 
the plant gum FTIR spectroscopic analysis were carried 
out. The drug, plant gum and optimized formulation 
blend i.e. batch F-3B (blend contain Prunus domestica 
gum, sodium diclofenac, Avicel and magnesium stearate) 
compatibility were studied by using IR spectrophotometer 
(Nicolet FTIR spectrophotometer, Thermoscientific 
Nicolet, USA). A small amount of sodium diclofenac, 
plant gum and formulation blend were respectively 
placed directly on the germanium piece of the infrared 
spectrometer with constant pressure applied and data 
of infrared absorbance, collected over the wave number 
ranged from 4000 cm-1 to 400 cm-1 and was expressed in 
cm-1 (Nazneen, Wesely, Johnson, 2012).
RESULTS AND DISCUSSION
The current study was undertaken to evaluate the 
binding potential of Prunus domestica gum using sodium 
diclofenac was used as model drug in formulation of tablets. 
The granules of different formulation batches prepared 
(as shown in Table I) were evaluated different parameters 
like angle of repose (θ), bulk and tapped densities, 
compressibility index, Hausner’s ratio and the results are 
(shown in Table II) angle of repose of all the formulated 
batches ranges from 29.34 to 35.86, indicating good flow 
properties (Reza, Mohammad, Yousef, 2012).
Physical characterization of all the batches (shown in 
Table III) showing acceptable values of thickness, weight 
variation (ranged from 199.25±3.89 to 201.50±3.17) was 
found within limit i.e. ±7.5 for the 200 mg tablet as per USP, 
hardness (ranged from 7.50±0.63 to 7.95±0.68 kg/cm2), 
friability (ranged from 0.14 to 0.67 %) within the 
acceptance range i.e. less than 1%, disintegration time 
( < 15 minutes) was found to be acceptable as all the 
batches and drug content (ranged from 98.02±0.75 to 
100.42±0.96%) was that claimed.
In-Vitro Dissolution Studies
In-vitro dissolution in phosphate buffer pH 6.8, 
batch F-2B (containing 7.5% Prunus domestica gum per 
total weight of tablet) release showed 98.67% of drug 
releases at the end of 50 min, which is compared with 
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TABLE II – Evaluation of granules
Properties F-1B F-2B  F-3B F-4B F-5B F-6B
Bulk density (g/ml) 0.577±0.00 0.592±0.01 0.601±0.00 0.488±0.00 0.491±0.00 0.494±0.00
Tapped density (g/ml) 0.636±0.01 0.662±0.01 0.660±0.01 0.582±0.00 0.580±0.00 0.590 ±0.01
Carr’s index 0.927±0.59 10.61±0.54 8.91±0.94 15.88±0.72 15.33±0.84 16.19±0.56
Hausner’s ratio 1.09±0.01 1.11±0.00 1.09±0.01 1.18±0.00 1.17±0.01 1.18±0.00
Angle of repose (˚) 32.04 31.41 29.34  35.86 34.07 33.49
All the values are expressed as mean ±SD
TABLE III – Evaluation of sodium dicloefenac tablets
Tablet 
Batches
Hardness
(Kg/cm2)
Weight variation 
(%)
Thickness 
(mm)
Friability* 
(%)
Disintegration 
time* (min)
Drug content 
(%)
F-1B
F-2B
F-3B
F-4B
F-5B
F-6B
7.50±0.63
7.83±0.58
7.95±0.68
7.94±0.63
7.77±0.51
7.65±0.65
200.80±3.24
200.30±3.15
200.80±3.22
199.25±3.89
201.50±3.17
200.48±3.56
4.32±1.04
4.32±1.08
4.31±1.12
4.36±1.13
4.34±1.03
4.30±0.91
0.67
0.54
0.42
0.38
0.24
0.14
3.40
8.20
13.30
4.40
9.10
15.00
98.02±0.75
98.99±0.65
100.34±1.09
98.62±0.72
100.42±0.96
99.36±1.04
All the values are expressed as mean ± SD except data denoted by asterisk (*)
TABLE IV - In-vitro release kinetics of diclofenac sodium tablets
Formulation
Zero Order First Order Higuchi Hixson Crowell Korsmeyer Release 
mechanism
r2 r2 r2 r2 r2 N
F-1B 0.8753 0.8001 0.9389 0.9512 0.9870 0.718 non-Fickian
F-2B 0.9907 0.9183 0.9320 0.9810 0.9722 0.781 non-Fickian
F-3B 0.9420 0.8879 0.7041 0.9172 0.7071 0.428 Fickian
F-4B 0.5640 0.5395 0.5619 0.6827 0.6873 0.240 Fickian
F-5B 0.8087 0.7706 0.7851 0.8847 0.8729 0.258 Fickian
F-6B 0.9809 0.9127 0.9871 0.9106 0.9742 0.712 non-Fickian
F-5B (containing standard binder PVP K30 at 7.5% of 
total weight of tablet) formulation showed 89.03% drug 
release at the end of 30 min. Batch F-3B (containing 10% 
of Prunus domestica gum) showed 74.86% drug release at 
the end of 60 min. Batch F-6B released 98.8% drug at the 
end of 60 min. Hence, it can be concluded that the binding 
potential of Prunus domestica better as compared to PVP 
K30. These results are shown in Figure 1.
Release Kinetics
All the batches obey zero order kinetics with values 
of r2 0.8753, 0.9907, 0.9420, 0.5640, 0.8087 and 0.9809 
for F-1B, F-2B, F-3B, F-4B, F-5B and F-6B respectively. 
Formulation batches F-3B, F-4B and F-5B follow Fickian 
FIGURE 1 – In Vitro drug release profile of sodium diclofenac 
tablets.
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(Case I) release, while the rest of batches obey Non-
Fickian type release pattern which mean that combination 
of erosion and diffusion controlled drug release is shown 
by the formulations, as evident from the Table V. A value of 
n = 0.45 indicates Fickian (case I) release; >0.45 but <0.89 
for non-Fickian (anomalous) release; and >0.89 indicates 
super case II type of release. Case II generally refers to the 
erosion of the polymeric chain and anomalous transport 
(non-Fickian) refers to a combination of both diffusion 
and erosion controlled-drug release.
Drug excipients compatibility studies
Drug excipients compatibilities studies were carried 
out by using IR spectroscopy. IR Spectra of Drug (sodium 
diclofenac) and optimized formulation F-3B (Drug, 
excipients and plant gum mixture) were analyzed. The 
IR spectra of pure diclofenac sodium and its physical 
mixtures with other excipients are shown in figures (2, 3 
and 4) and interpretations were listed in Table VI.
The distinct peaks of pure drug were at 3251.5, 
3084.0, 1573.5, 1281.5, 844.4 cm-1, while the batch 
containing Prunus domestica gum as binder showed 
peaks at 3221.0, 2917.9, 1572.7, 1306.2, 1035.6 and 
838.5 cm-1. The distinct peaks are appeared in both pure 
TABLE V – In vitro release kinetics of sodium diclofenac tablets
Bonds/Group Absorption range in cm-1 Pure Drug Formulation F-3B
- NH 3500-3200 3251.3 3221.0
C-H 3100-2850 3084.0 2917.9
C=C 1900-1500 1573.5 1572.7
C-Cl 1280-1350 1281.5 1306.2
C-N 1300-800 1044.1 1035.6
C-C 850-550 844.4 838.5
Drug excipients compatibility studies
TABLE VI – For FTIR data interpretation
Formulation
Zero Order First Order Higuchi Hixson Crowell Korsmeyer Release 
mechanism
r2 r2 r2 r2 r2 N
F-1B 0.8753 0.8001 0.9389 0.9512 0.9870 0.718 non-Fickian
F-2B 0.9907 0.9183 0.9320 0.9810 0.9722 0.781 non-Fickian
F-3B 0.9420 0.8879 0.7041 0.9172 0.7071 0.428 Fickian
F-4B 0.5640 0.5395 0.5619 0.6827 0.6873 0.240 Fickian
F-5B 0.8087 0.7706 0.7851 0.8847 0.8729 0.258 Fickian
F-6B 0.9809 0.9127 0.9871 0.9106 0.9742 0.712 non-Fickian
FIGURE 2 – FTIR spectrum Prunus domestica gum.
FIGURE 3 – FTIR spectrum sodium diclofenac.
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drug (diclofenac sodium) and formulation containing 
Prunus domestica gum, indicating no chemical interaction 
between diclofenac sodium and Prunus domestica gum 
as confirmed by FTIR. Hence, the gum is safe to use as 
an excipient in formulation of Diclofenac sodium tablets.
CONCLUSION
Batch F-2B release showed 50.23% of drug releases 
at the end of 30 min, which is compared with F-5B 
formulation, showed 89.03% drug release at the end of 30 
min. Batch F-3B showed 74.86% drug release at the end of 
60 min while batch F-6B released 98.8% drug at the end of 
60 min. Hence, it is concluded that Prunus domestica has 
better binding potential as compared to PVP K30. Hence, 
Prunus domestica gum, a natural excipient, can be used 
as a binder in tablet formulations.
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